Published in J Allergy Clin Immunol on February 08, 2012
Impact of atopic dermatitis and loss-of-function mutations in the filaggrin gene on the development of occupational irritant contact dermatitis. Br J Dermatol (2013) 1.43
Deciphering the complexities of atopic dermatitis: shifting paradigms in treatment approaches. J Allergy Clin Immunol (2014) 1.31
Food allergy: an enigmatic epidemic. Trends Immunol (2013) 1.00
Skin barrier defects in atopic dermatitis. Curr Allergy Asthma Rep (2014) 0.91
Spontaneous atopic dermatitis is mediated by innate immunity, with the secondary lung inflammation of the atopic march requiring adaptive immunity. J Allergy Clin Immunol (2015) 0.91
Mutations in the Filaggrin are Predisposing Factor in Korean Children With Atopic Dermatitis. Allergy Asthma Immunol Res (2013) 0.87
Genetic and epigenetic studies of atopic dermatitis. Allergy Asthma Clin Immunol (2016) 0.83
IL-25 enhances HSV-1 replication by inhibiting filaggrin expression, and acts synergistically with Th2 cytokines to enhance HSV-1 replication. J Invest Dermatol (2013) 0.81
Cytokines and chemokines in irritant contact dermatitis. Mediators Inflamm (2013) 0.80
Filaggrin silencing by shRNA directly impairs the skin barrier function of normal human epidermal keratinocytes and then induces an immune response. Braz J Med Biol Res (2014) 0.80
Atopic dermatitis in children: clinical features, pathophysiology, and treatment. Immunol Allergy Clin North Am (2014) 0.79
Risk factor-dependent dynamics of atopic dermatitis: modelling multi-scale regulation of epithelium homeostasis. Interface Focus (2013) 0.78
The immunology of atopic dermatitis and its reversibility with broad-spectrum and targeted therapies. J Allergy Clin Immunol (2017) 0.77
Exacerbation of allergen-induced eczema in TLR4- and TRIF-deficient mice. J Immunol (2013) 0.77
Tape Stripping Technique for Stratum Corneum Protein Analysis. Sci Rep (2016) 0.76
An mTORC1/AKT1/Cathepsin H axis controls filaggrin expression and processing in skin, a novel mechanism for skin barrier disruption in Atopic Dermatitis. J Allergy Clin Immunol (2016) 0.75
Spontaneous atopic dermatitis-like symptoms in a/a ma ft/ma ft/J flaky tail mice appear early after birth. PLoS One (2013) 0.75
Inactivation of mitogen-activated protein kinase signaling pathway reduces caspase-14 expression in impaired keratinocytes. Iran J Basic Med Sci (2016) 0.75
Skin barrier in atopic dermatitis: beyond filaggrin. An Bras Dermatol (2016) 0.75
Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis? An Bras Dermatol (2016) 0.75
IL-17 Receptor A Maintains and Protects the Skin Barrier To Prevent Allergic Skin Inflammation. J Immunol (2017) 0.75
Clumping factor B promotes adherence of Staphylococcus aureus to corneocytes in atopic dermatitis. Infect Immun (2017) 0.75
Alterations in epidermal eicosanoid metabolism contribute to inflammation and impaired late differentiation in FLG-mutated AD. J Invest Dermatol (2016) 0.75
Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc (2008) 62.52
Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol (2009) 14.33
Active caspase-1 is a regulator of unconventional protein secretion. Cell (2008) 5.89
Atopic dermatitis. Lancet (2003) 4.14
The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol (2001) 3.58
The U.K. Working Party's Diagnostic Criteria for Atopic Dermatitis. I. Derivation of a minimum set of discriminators for atopic dermatitis. Br J Dermatol (1994) 3.45
Cytokine milieu of atopic dermatitis, as compared to psoriasis, skin prevents induction of innate immune response genes. J Immunol (2003) 3.41
Filaggrin mutations associated with skin and allergic diseases. N Engl J Med (2011) 3.40
Mechanisms of regulated unconventional protein secretion. Nat Rev Mol Cell Biol (2008) 3.17
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet (2009) 2.96
Cytokine modulation of atopic dermatitis filaggrin skin expression. J Allergy Clin Immunol (2007) 2.79
Atopic dermatitis: new insights and opportunities for therapeutic intervention. J Allergy Clin Immunol (2000) 2.46
Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery. J Invest Dermatol (2008) 2.20
Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol (2008) 2.11
Identification of calcium-activated neutral protease as a processing enzyme of human interleukin 1 alpha. Proc Natl Acad Sci U S A (1990) 1.94
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2008) 1.89
Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice. J Clin Invest (1992) 1.88
The skin barrier as an innate immune element. Semin Immunopathol (2007) 1.81
Long-term culture of murine epidermal keratinocytes. J Invest Dermatol (1999) 1.79
pH directly regulates epidermal permeability barrier homeostasis, and stratum corneum integrity/cohesion. J Invest Dermatol (2003) 1.75
Perturbation of epidermal barrier function correlates with initiation of cytokine cascade in human skin. J Am Acad Dermatol (1994) 1.72
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol (2008) 1.67
The emerging roles of serine protease cascades in the epidermis. Trends Biochem Sci (2009) 1.64
Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy (2011) 1.59
A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol (2005) 1.58
Serine protease signaling of epidermal permeability barrier homeostasis. J Invest Dermatol (2006) 1.51
Abnormal skin barrier in the etiopathogenesis of atopic dermatitis. Curr Opin Allergy Clin Immunol (2009) 1.43
Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol (2011) 1.41
Interleukin-1 and cutaneous inflammation: a crucial link between innate and acquired immunity. J Invest Dermatol (2000) 1.40
The Nottingham Eczema Severity Score: preliminary refinement of the Rajka and Langeland grading. Br J Dermatol (2000) 1.34
The expression and modulation of IL-1 alpha in murine keratinocytes. J Immunol (1988) 1.25
Raman profiles of the stratum corneum define 3 filaggrin genotype-determined atopic dermatitis endophenotypes. J Allergy Clin Immunol (2010) 1.23
Barrier disruption stimulates interleukin-1 alpha expression and release from a pre-formed pool in murine epidermis. J Invest Dermatol (1996) 1.20
Does the tail wag the dog? Role of the barrier in the pathogenesis of inflammatory dermatoses and therapeutic implications. Arch Dermatol (2001) 1.19
Stratum corneum lipids, skin barrier function and filaggrin mutations in patients with atopic eczema. Allergy (2010) 1.19
Participation of a cathepsin L-type protease in the activation of caspase-3. Cell Struct Funct (1999) 1.17
Neutrophil serine proteases: potential key regulators of cell signalling during inflammation. J Intern Med (2005) 1.15
Differential in vivo cytokine mRNA expression in lesional skin of intrinsic vs. extrinsic atopic dermatitis patients using semiquantitative RT-PCR. Clin Exp Allergy (2003) 1.14
Effect of filaggrin breakdown products on growth of and protein expression by Staphylococcus aureus. J Allergy Clin Immunol (2010) 1.12
Natural moisturizing factor components in the stratum corneum as biomarkers of filaggrin genotype: evaluation of minimally invasive methods. Br J Dermatol (2009) 1.08
Skin barrier function in healthy subjects and patients with atopic dermatitis in relation to filaggrin loss-of-function mutations. J Invest Dermatol (2010) 1.04
Mite serine protease activates protease-activated receptor-2 and induces cytokine release in human keratinocytes. Allergy (2009) 1.02
IL-1 beta activation in human epidermis. J Immunol (1996) 1.01
Formation of active IL-1 beta from pro-IL-1 beta catalyzed by stratum corneum chymotryptic enzyme in vitro. Acta Derm Venereol (1997) 1.00
Interleukin-1 receptor antagonist suppresses contact hypersensitivity. J Invest Dermatol (1995) 0.99
Interleukin-1, inflammasomes and the skin. Eur J Cell Biol (2010) 0.99
Crucial commitment of proteolytic activity of a purified recombinant major house dust mite allergen Der p1 to sensitization toward IgE and IgG responses. J Immunol (2006) 0.98
Alterations in cytokine regulation in aged epidermis: implications for permeability barrier homeostasis and inflammation. I. IL-1 gene family. Exp Dermatol (2002) 0.97
Imiquimod-induced interleukin-1 alpha stimulation improves barrier homeostasis in aged murine epidermis. J Invest Dermatol (2004) 0.94
Induction of biologically active IL-1 beta-converting enzyme and mature IL-1 beta in human keratinocytes by inflammatory and immunologic stimuli. J Immunol (1997) 0.94
Cytokines at different stratum corneum levels in normal and sodium lauryl sulphate-irritated skin. Skin Res Technol (2007) 0.93
Staphylococcus aureus extracellular protease causes epidermal barrier dysfunction. J Invest Dermatol (2009) 0.90
Proteolytically active allergens cause barrier breakdown. J Invest Dermatol (2008) 0.87
Epidermal cytokines IL-1beta, TNF-alpha, and IL-12 in patients with atopic dermatitis: response to application of house dust mite antigens. J Invest Dermatol (1998) 0.86
An increased ratio of interleukin-1 receptor antagonist to interleukin-1alpha in inflammatory skin diseases. Exp Dermatol (1998) 0.82
Interleukin-18 is elevated in the horny layer in patients with atopic dermatitis and is associated with Staphylococcus aureus colonization. Br J Dermatol (2011) 0.82
Calcium metabolism and the pathogenesis of dermatologic disease. Semin Dermatol (1991) 0.79
Atopic dermatitis. Clin Allergy Immunol (2002) 0.78
Caspase-1 activity of stratum corneum and serum interleukin-18 level are increased in patients with Netherton syndrome. Br J Dermatol (2008) 0.76
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity. Nature (2010) 10.34
Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis. Nat Genet (2006) 9.99
A genome-wide association study identifies new psoriasis susceptibility loci and an interaction between HLA-C and ERAP1. Nat Genet (2010) 8.48
Loss-of-function mutations in the gene encoding filaggrin cause ichthyosis vulgaris. Nat Genet (2006) 4.55
Comprehensive analysis of the gene encoding filaggrin uncovers prevalent and rare mutations in ichthyosis vulgaris and atopic eczema. Nat Genet (2007) 3.94
Transcription factor RORα is critical for nuocyte development. Nat Immunol (2012) 3.72
Filaggrin mutations associated with skin and allergic diseases. N Engl J Med (2011) 3.40
A homozygous frameshift mutation in the mouse Flg gene facilitates enhanced percutaneous allergen priming. Nat Genet (2009) 2.96
The hydroxylase inhibitor dimethyloxalylglycine is protective in a murine model of colitis. Gastroenterology (2007) 2.87
Intermediate filament proteins and their associated diseases. N Engl J Med (2004) 2.84
The gene encoding R-spondin 4 (RSPO4), a secreted protein implicated in Wnt signaling, is mutated in inherited anonychia. Nat Genet (2006) 2.81
Loss of kindlin-1, a human homolog of the Caenorhabditis elegans actin-extracellular-matrix linker protein UNC-112, causes Kindler syndrome. Am J Hum Genet (2003) 2.73
Filaggrin in the frontline: role in skin barrier function and disease. J Cell Sci (2009) 2.71
IL-10 is an important mediator of the enhanced susceptibility to pneumococcal pneumonia after influenza infection. J Immunol (2004) 2.59
The burden of disease associated with filaggrin mutations: a population-based, longitudinal birth cohort study. J Allergy Clin Immunol (2008) 2.53
Clinical and pathological features of pachyonychia congenita. J Investig Dermatol Symp Proc (2005) 2.45
Lipoid proteinosis maps to 1q21 and is caused by mutations in the extracellular matrix protein 1 gene (ECM1). Hum Mol Genet (2002) 2.41
Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations. J Allergy Clin Immunol (2006) 2.22
Breaking the (un)sound barrier: filaggrin is a major gene for atopic dermatitis. J Invest Dermatol (2006) 2.17
Filaggrin mutations, atopic eczema, hay fever, and asthma in children. J Allergy Clin Immunol (2008) 2.16
Regulatory B cells prevent and reverse allergic airway inflammation via FoxP3-positive T regulatory cells in a murine model. J Allergy Clin Immunol (2010) 2.15
Psychiatric disorders from childhood to adulthood in 22q11.2 deletion syndrome: results from the International Consortium on Brain and Behavior in 22q11.2 Deletion Syndrome. Am J Psychiatry (2014) 2.15
A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis. J Exp Med (2013) 2.11
IL-18 attenuates experimental choroidal neovascularization as a potential therapy for wet age-related macular degeneration. Sci Transl Med (2014) 2.11
One remarkable molecule: filaggrin. J Invest Dermatol (2011) 2.10
The alarmin interleukin-33 drives protective antiviral CD8⁺ T cell responses. Science (2012) 2.10
Infection with a helminth parasite prevents experimental colitis via a macrophage-mediated mechanism. J Immunol (2007) 2.09
Meta-analysis of filaggrin polymorphisms in eczema and asthma: robust risk factors in atopic disease. J Allergy Clin Immunol (2009) 2.03
Null mutations in the filaggrin gene (FLG) determine major susceptibility to early-onset atopic dermatitis that persists into adulthood. J Invest Dermatol (2006) 2.00
A lack of premature termination codon read-through efficacy of PTC124 (Ataluren) in a diverse array of reporter assays. PLoS Biol (2013) 1.98
The Human Intermediate Filament Database: comprehensive information on a gene family involved in many human diseases. Hum Mutat (2008) 1.97
Neutralisation of the interleukin-33/ST2 pathway ameliorates experimental colitis through enhancement of mucosal healing in mice. Gut (2012) 1.97
Intragenic copy number variation within filaggrin contributes to the risk of atopic dermatitis with a dose-dependent effect. J Invest Dermatol (2011) 1.97
3D analysis of facial morphology. Am J Med Genet A (2004) 1.95
Recurrent mutations in kindlin-1, a novel keratinocyte focal contact protein, in the autosomal recessive skin fragility and photosensitivity disorder, Kindler syndrome. J Invest Dermatol (2004) 1.95
Caspase-14 is required for filaggrin degradation to natural moisturizing factors in the skin. J Invest Dermatol (2011) 1.93
Schistosoma mansoni worms induce anergy of T cells via selective up-regulation of programmed death ligand 1 on macrophages. J Immunol (2004) 1.91
Filaggrin in atopic dermatitis. J Allergy Clin Immunol (2008) 1.89
Loss of APC induces polyploidy as a result of a combination of defects in mitosis and apoptosis. J Cell Biol (2007) 1.77
The multifunctional role of filaggrin in allergic skin disease. J Allergy Clin Immunol (2013) 1.74
Monitoring the penetration enhancer dimethyl sulfoxide in human stratum corneum in vivo by confocal Raman spectroscopy. Pharm Res (2002) 1.73
SIGN-R1 contributes to protection against lethal pneumococcal infection in mice. J Exp Med (2004) 1.73
Toward a major risk factor for atopic eczema: meta-analysis of filaggrin polymorphism data. J Allergy Clin Immunol (2007) 1.71
Discriminating power of localized three-dimensional facial morphology. Am J Hum Genet (2005) 1.71
Loss-of-function variants in the filaggrin gene are a significant risk factor for peanut allergy. J Allergy Clin Immunol (2011) 1.68
Loss-of-function mutations in the filaggrin gene lead to reduced level of natural moisturizing factor in the stratum corneum. J Invest Dermatol (2008) 1.67
Development of therapeutic siRNAs for pachyonychia congenita. J Invest Dermatol (2007) 1.67
Generic and personalized RNAi-based therapeutics for a dominant-negative epidermal fragility disorder. J Invest Dermatol (2012) 1.66
Loss of prolyl hydroxylase-1 protects against colitis through reduced epithelial cell apoptosis and increased barrier function. Gastroenterology (2010) 1.64
Novel mechanism of revertant mosaicism in Dowling-Meara epidermolysis bullosa simplex. J Invest Dermatol (2004) 1.63
Prevalent and rare mutations in the gene encoding filaggrin cause ichthyosis vulgaris and predispose individuals to atopic dermatitis. J Invest Dermatol (2006) 1.62
Levels of filaggrin degradation products are influenced by both filaggrin genotype and atopic dermatitis severity. Allergy (2011) 1.59
Filaggrin's fuller figure: a glimpse into the genetic architecture of atopic dermatitis. J Invest Dermatol (2007) 1.57
Helminth infection protects mice from anaphylaxis via IL-10-producing B cells. J Immunol (2004) 1.57
Comparative PRKAR1A genotype-phenotype analyses in humans with Carney complex and prkar1a haploinsufficient mice. Proc Natl Acad Sci U S A (2004) 1.56
Detection of meningioma in dura mater by Raman spectroscopy. Anal Chem (2005) 1.55
Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol (2003) 1.55
Glucocorticoid-induced changes in gene expression of airway smooth muscle in patients with asthma. Am J Respir Crit Care Med (2013) 1.54
Discriminating basal cell carcinoma from its surrounding tissue by Raman spectroscopy. J Invest Dermatol (2002) 1.54
Discriminating basal cell carcinoma from perilesional skin using high wave-number Raman spectroscopy. J Biomed Opt (2007) 1.53
The persistence of atopic dermatitis and filaggrin (FLG) mutations in a US longitudinal cohort. J Allergy Clin Immunol (2012) 1.52
Keratin K6c mutations cause focal palmoplantar keratoderma. J Invest Dermatol (2009) 1.51
T1/ST2 expression on Th2 cells negatively regulates allergic pulmonary inflammation. Eur J Immunol (2007) 1.50